Thilo Schroeder
Directeur/Membre du Conseil chez REVOLUTION MEDICINES, INC.
Provenance du réseau au premier degré de Thilo Schroeder
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 25 | |
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.
21
| Private Company | Investment Managers | 21 |
| Public Company | Miscellaneous Commercial Services | 15 | |
| Extinct | Pharmaceuticals: Major | 14 | |
| Public Company | Pharmaceuticals: Major | 13 | |
Circle Pharma, Inc.
 Circle Pharma, Inc. BiotechnologyHealth Technology Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA.
9
| Holding Company | Biotechnology | 9 |
| Subsidiary | Pharmaceuticals: Major | 8 | |
| Public Company | Biotechnology | 7 | |
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA.
6
| Holding Company | Medical Specialties | 6 |
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA.
5
| Holding Company | Biotechnology | 5 |
Exo Therapeutics, Inc.
 Exo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Exo Therapeutics, Inc. engages in production of drugs. It has developed a small-molecule enzyme inhibitor discovery platform that targets distal binding pockets of enzymes (exo-sites) that are not evolutionarily conserved. The company was founded by David R. Liu and Alan Saghatelian and is headquartered in Boston, MA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Alterome Therapeutics, Inc.
 Alterome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alterome Therapeutics, Inc. is a precision oncology biotech that develops alteration-specific therapeutics to address high-value and validated oncogenic drivers. The company is based in San Marcos, CA. The company is led by seasoned R&D leaders with a history of developing marketed oncology small molecule drugs. The company's mission is to discover precise therapies and inspire hope for individuals affected by cancer. The CEO of the company is Eric A. Murphy.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thilo Schroeder via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Corporate Officer/Principal | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Founder Director/Board Member Director/Board Member Founder Corporate Officer/Principal | |
| RELAY THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member Director/Board Member Director/Board Member Founder Founder | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Founder Private Equity Investor Private Equity Investor Director of Finance/CFO | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Consultant / Advisor Director/Board Member Founder Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Investment Managers | Founder Corporate Officer/Principal Private Equity Investor Chief Operating Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Private Equity Investor Comptroller/Controller/Auditor | |
| SYNTHORX, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Director/Board Member Founder Director/Board Member | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Founder | |
| MEDIVATION INC | Pharmaceuticals: Major | General Counsel Director/Board Member Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
| EQRX, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Founder | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal President Director/Board Member | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Founder | |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Founder | |
Thrive Earlier Detection Corp.
 Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Thrive Earlier Detection Corp. operates as a healthcare company. It focuses on incorporating earlier cancer detection into routine medical care. The company was founded by Bert Vogelstein, Kenneth W. Kinzler, Isaac Kinde, Christoph S. Lengauer, and Nickolas Papadopoulos in 2019 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
| Georgetown University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
Celsius Therapeutics, Inc.
 Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel Founder | |
| KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Doctorate Degree Graduate Degree | |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Basel | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Washington University School of Medicine | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 49 |
| Royaume-Uni | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 5 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 574 |
| Corporate Officer/Principal | 194 |
| Independent Dir/Board Member | 187 |
| Undergraduate Degree | 78 |
| Chairman | 72 |
Relations les plus connectées
| Insiders | |
|---|---|
| Peter Thompson | 39 |
| Carol Gallagher | 39 |
| Helen Kim | 33 |
| Richard Heyman | 33 |
| Neil Exter | 33 |
| Walter Moos | 30 |
| Timothy Irish | 29 |
| John D. Diekman | 29 |
| Jon Root | 28 |
| Vickie Capps | 27 |
| Larry Lasky | 27 |
| Alexis Borisy | 25 |
| Charles Rowland | 25 |
| Peter Svennilson | 25 |
| Elizabeth Anderson | 24 |
- Bourse
- Insiders
- Thilo Schroeder
- Connexions Sociétés
